News | September 30, 2011

First Robotic Radiosurgery Prostate Cancer Registry Enrolls More than 500 Men

September 30, 2011 — The CyberKnife Coalition announced that more than 500 men have been enrolled in the first national patient registry designed to track prostate cancer patients treated with stereotactic body radiation therapy (SBRT). All of the patients were treated with the CyberKnife Robotic Radiosurgery System.

The multi-institutional Registry for Prostate Cancer Radiosurgery (RPCR) tracks clinical and functional outcomes of men with localized prostate cancer treated at academic and community based centers throughout the United States.

Launched in July 2010, the RPCR is an independent, Institutional Review Board (IRB)-approved observational trial registered with clinicaltrials.gov. It is designed to collect information that will be useful in determining the role of radiosurgical treatment for patients with early-stage prostate cancer.

In addition to tracking clinical data the registry also collects patient selection and quality of life information, which will be reported to the Centers for Medicare & Medicaid Services (CMS) and local Medicare contractors.

By participating in the registry, CyberKnife centers will be better equipped to help patients make the best decision for their individual circumstances, a view shared by the Agency for Healthcare Quality and Research. The agency published a patient guide earlier this month entitled 'Knowing your Treatment Options', an overview of prostate cancer treatment options, that for the first time included SBRT as a treatment option for men with localized prostate cancer.

For more information: www.ckcoalition.org

Related Content

Sponsored Content | Videos | Proton Therapy | August 21, 2017
Mark Pankuch, Ph.D., director of medical physics at the Northwestern Medicine Chicago Proton Center, discusses the cl
Summit Cancer Center-Boise Treats First Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | August 21, 2017
Accuray Inc. and the Summit Cancer Center-Boise announced that the center is now treating patients with the Radixact...
MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Overlay Init